ZYXI - Rasio utang marang kapitalisasi buku Zynex Medical

Logo korporat perusahaan Zynex, Inc. (ZYXI)

Zynex, Inc. relies on robust liquidity and a steady stream of funds from medical centers. High margins are driven by the multi-year procurement of consumables and electrodes by patients. Fluctuations in the debt-to-equity ratio clearly demonstrate financial stability, where 0.00 becomes the new value of the indicator. The final outcome depends on government policy regarding non-drug pain management and the recognition of electrotherapy methods by physicians.

Zynex, Inc. - Utang-utang marang kapitalisasi buku ZYXI (periode 04.07.2022 - 03.01.2026)
Barang unggulan Zynex Corp

This indicator measures the degree of the business's reliance on borrowed funds relative to its equity. The calculation is based on a dynamic comparison of all liabilities against the book value of assets. By analyzing the ratio of debt obligations to book capital, an investor assesses the financial stability of Zynex, Inc. (ZYXI). A low debt load confirms the company's reliability, allowing it to effectively leverage its leadership in electrotherapy for expansion without the risk of excessive credit dependence.

Pesaing Zynex, Inc.

DXCM: Utang-utang marang kapitalisasi buku|penumbrainc.com - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Novanta (NOVT)|HAE - Rasio utang marang aset resik|INSP: Utang-utang marang kapitalisasi buku|PRCT (Procept) - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku CONMED Corporation CNMD|Rasio utang-utang marang kapitalisasi buku pulsebiosciences.com|InMode - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku Picard Medical Corp PMI|Utang marang nilai buku SRDX (Surmodics Corp)|SENS - Utang-utang marang kapitalisasi buku|Utang marang nilai buku NeuroPace, Inc. NPCE|TCMD - Utang marang modal buku|SANUWAVE - Utang-utang marang kapitalisasi buku|Outset Medical Inc (OM) - Utang-utang marang aset resik|Utang-utang marang kapitalisasi buku ELMD|Utang marang nilai buku LENSAR Inc (LNSR)|AVITA Medical, Inc. (RCEL) - Utang marang nilai buku|Rasio utang marang aset resik PROF (profoundmedical.com)|Baird Medical - Rasio utang marang kapitalisasi buku|Utang marang nilai buku EDAP TMS SA EDAP|APYX (Bovie Medical) - Utang-utang marang kapitalisasi buku|ICCM - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku pulmonx.com|TELA Bio (TELA) - Rasio utang marang nilai buku|CTSO: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Sensus Healthcare Inc|Utang-utang marang kapitalisasi buku ECOR (electroCore, Inc.)|Utang marang nilai buku vicarioussurgical.com (RBOT)|Utang-utang marang kapitalisasi buku IINN (Inspira Technologies)|seastarmedical.com - Utang-utang marang kapitalisasi buku|IRIX - Rasio utang marang kapitalisasi buku|Intelligent Bio Solutions (INBS) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku beyondair.net XAIR|Profusa, Inc (PFSA) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku SSKN (STRATA Skin Sciences Inc.)|Utang-utang marang nilai buku GCTK|NAOV: Rasio utang marang kapitalisasi buku|Utang marang aset resik Venus Concept Inc VERO|Utang marang nilai buku NUWE (CHF Solutions)|Utang-utang marang kapitalisasi buku Aethlon Medical Corp AEMD|Utang-utang marang kapitalisasi buku ASXC (TransEnterix)|AVGR: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Biosig Technologies (BSGM)|CUTR (Cutera Inc.) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku KNW|Utang marang nilai buku Inari Medical Corp|Nevro Corp. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku RSLS (reshapelifesciences.com)|SILK - Rasio utang marang kapitalisasi buku